Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Zoledronate inhibits phosphate and bone morphogenetic protein 2-induced extracellular calcification of vascular smooth muscle cells in vitro.

Hu ML, Huang Y, Zheng ZH, Lei Y, Liu RJ, Wang XH, Lindholm B, Yu XQ.

Exp Ther Med. 2012 May;3(5):841-844. Epub 2012 Mar 1.

2.

Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.

Zhou Y, Wang JY, Feng H, Wang C, Li L, Wu D, Lei H, Li H, Wu LL.

Arterioscler Thromb Vasc Biol. 2014 May;34(5):1002-10. doi: 10.1161/ATVBAHA.114.303301. Epub 2014 Feb 27.

3.

BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells.

Li X, Yang HY, Giachelli CM.

Atherosclerosis. 2008 Aug;199(2):271-7. doi: 10.1016/j.atherosclerosis.2007.11.031. Epub 2008 Jan 7.

4.

Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells.

Suzuki A, Ghayor C, Guicheux J, Magne D, Quillard S, Kakita A, Ono Y, Miura Y, Oiso Y, Itoh M, Caverzasio J.

J Bone Miner Res. 2006 May;21(5):674-83.

5.

Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells.

Chavkin NW, Chia JJ, Crouthamel MH, Giachelli CM.

Exp Cell Res. 2015 Apr 10;333(1):39-48. doi: 10.1016/j.yexcr.2015.02.002. Epub 2015 Feb 13.

6.

Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2.

Crouthamel MH, Lau WL, Leaf EM, Chavkin NW, Wallingford MC, Peterson DF, Li X, Liu Y, Chin MT, Levi M, Giachelli CM.

Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2625-32. doi: 10.1161/ATVBAHA.113.302249. Epub 2013 Aug 22.

7.

Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium.

Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, van Leeuwen FN, Touyz RM.

Hypertension. 2010 Sep;56(3):453-62. doi: 10.1161/HYPERTENSIONAHA.110.152058. Epub 2010 Aug 9.

8.

Smad3 plays an inhibitory role in phosphate-induced vascular smooth muscle cell calcification.

Shimokado A, Sun Y, Nakanishi M, Sato F, Oikawa K, Akasaka T, Muragaki Y.

Exp Mol Pathol. 2014 Dec;97(3):458-64. doi: 10.1016/j.yexmp.2014.10.005. Epub 2014 Oct 7.

PMID:
25303897
9.

Macrophages play a unique role in the plaque calcification by enhancing the osteogenic signals exerted by vascular smooth muscle cells.

Ikeda K, Souma Y, Akakabe Y, Kitamura Y, Matsuo K, Shimoda Y, Ueyama T, Matoba S, Yamada H, Okigaki M, Matsubara H.

Biochem Biophys Res Commun. 2012 Aug 17;425(1):39-44. doi: 10.1016/j.bbrc.2012.07.045. Epub 2012 Jul 17.

PMID:
22820183
10.

The calcimimetic calindol prevents high phosphate-induced vascular calcification by upregulating matrix GLA protein.

Ciceri P, Elli F, Brenna I, Volpi E, Brancaccio D, Cozzolino M.

Nephron Exp Nephrol. 2012;122(3-4):75-82. doi: 10.1159/000349935. Epub 2013 Mar 28.

PMID:
23548867
11.

Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro.

Sage AP, Lu J, Tintut Y, Demer LL.

Kidney Int. 2011 Feb;79(4):414-22. doi: 10.1038/ki.2010.390. Epub 2010 Oct 13.

12.

Apelin: A novel inhibitor of vascular calcification in chronic kidney disease.

Han X, Wang LY, Diao ZL, Liu WH.

Atherosclerosis. 2016 Jan;244:1-8. doi: 10.1016/j.atherosclerosis.2015.10.102. Epub 2015 Oct 30.

PMID:
26581047
13.

APE1/Ref-1 Inhibits Phosphate-Induced Calcification and Osteoblastic Phenotype Changes in Vascular Smooth Muscle Cells.

Lee KM, Lee EO, Lee YR, Joo HK, Park MS, Kim CS, Choi S, Jeong JO, Jeon BH.

Int J Mol Sci. 2017 Sep 25;18(10). pii: E2053. doi: 10.3390/ijms18102053.

14.

BMP9/COX-2 axial mediates high phosphate-induced calcification in vascular smooth muscle cells via Wnt/β-catenin pathway.

He F, Wang H, Ren WY, Ma Y, Liao YP, Zhu JH, Cui J, Deng ZL, Su YX, Gan H, He BC.

J Cell Biochem. 2017 Oct 26. doi: 10.1002/jcb.26460. [Epub ahead of print]

PMID:
29073723
15.
16.

Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells.

Wu L, Zhu L, Shi WH, Zhang J, Ma D, Yu B.

Eur J Pharmacol. 2009 Jan 5;602(1):124-31. doi: 10.1016/j.ejphar.2008.10.043. Epub 2008 Oct 31.

PMID:
19000670
17.

MiR-29-mediated elastin down-regulation contributes to inorganic phosphorus-induced osteoblastic differentiation in vascular smooth muscle cells.

Sudo R, Sato F, Azechi T, Wachi H.

Genes Cells. 2015 Dec;20(12):1077-87. doi: 10.1111/gtc.12311. Epub 2015 Nov 27.

18.

Bone morphogenetic protein-7 inhibits vascular calcification induced by high vitamin D in mice.

Kang YH, Jin JS, Yi DW, Son SM.

Tohoku J Exp Med. 2010 Aug;221(4):299-307.

19.

Rat aortic smooth muscle cells cultured on hydroxyapatite differentiate into osteoblast-like cells via BMP-2-SMAD-5 pathway.

Nahar-Gohad P, Gohad N, Tsai CC, Bordia R, Vyavahare N.

Calcif Tissue Int. 2015 Apr;96(4):359-69. doi: 10.1007/s00223-015-9962-z. Epub 2015 Mar 1.

20.

Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt/β-catenin pathway.

Rong S, Zhao X, Jin X, Zhang Z, Chen L, Zhu Y, Yuan W.

Cell Physiol Biochem. 2014;34(6):2049-60. doi: 10.1159/000366400. Epub 2014 Nov 28.

Supplemental Content

Support Center